Therapeutic options for the prevention of type 2 diabetes mellitus in the metabolic syndrome.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  The Mount Sinai journal of medicine, New York

• Publication date

  2010-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/msj.20204PMID 20960554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis.

  2010cited by this paper
• Early Postoperative Insulin-Resistance Changes After Sleeve Gastrectomy

  2010cited by this paper
• Managing Highly Insulin-Resistant Diabetes Mellitus: Weight Loss Approaches and Medical Management

  2010cited by this paper
• Smoking, Smoking Cessation, and Risk for Type 2 Diabetes Mellitus

  2010cited by this paper
• Effect of valsartan on the incidence of diabetes and cardiovascular events.

  2010cited by this paper
• Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome.

  2010cited by this paper
• 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.

  2009cited by this paper
• Colesevelam HCl Improves Fasting Plasma Glucose and Lipid Levels in Patients with Prediabetes

  2009cited by this paper
• Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.

  2009cited by this paper
• Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis.

  2009cited by this paper
• Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As

  2009cited by this paper
• Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARα in high fat diet-induced obese mice

  2009cited by this paper
• Alcohol consumption and diabetes risk in the Diabetes Prevention Program.

  2009cited by this paper
• Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.

  2008cited by this paper
• Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy

  2008cited by this paper
• Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity

  2008cited by this paper
• Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes

  2008cited by this paper
• Exenatide use in the management of metabolic syndrome: a retrospective database study.

  2008cited by this paper
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008cited by this paper
• Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis.

  2007cited by this paper
• Effect of ramipril on the incidence of diabetes.

  2007cited by this paper
• Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin

  2007cited by this paper
• Biology of incretins: GLP-1 and GIP.

  2007cited by this paper
• Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials.

  2007cited by this paper
• Treating Postprandial Hyperglycemia Does Not Appear to Delay Progression of Early Type 2 Diabetes

  2006cited by this paper
• Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes.

  2006cited by this paper
• Therapeutic approaches to preserve islet mass in type 2 diabetes.

  2006cited by this paper
• Ethnicity, Obesity, and Risk of Type 2 Diabetes in Women

  2006cited by this paper
• Cereal fiber improves whole-body insulin sensitivity in overweight and obese women.

  2006cited by this paper
• Effect of ramipril on the incidence of diabetes.

  2006cited by this paper
• Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study

  2006cited by this paper
• Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance.

  2006cited by this paper
• Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women.

  2006cited by this paper
• Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years After Bariatric Surgery

  2006cited by this paper
• Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression.

  2006cited by this paper
• Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.

  2005cited by this paper
• Mechanisms of Reactive Oxygen Species–Dependent Downregulation of Insulin Receptor Substrate-1 by Angiotensin II

  2005cited by this paper
• Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies.

  2005cited by this paper
• The effects of orlistat on metabolic parameters and other cardiovascular risk factors.

  2005cited by this paper
• Meta-Analysis: Pharmacologic Treatment of Obesity

  2005cited by this paper
• Sibutramine improves fat distribution and insulin resistance, and increases serum adiponectin levels in Korean obese nondiabetic premenopausal women.

  2004cited by this paper
• Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

  2004cited by this paper
• XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.

  2004cited by this paper
• The Early Effect of the Roux-en-Y Gastric Bypass on Hormones Involved in Body Weight Regulation and Glucose Metabolism

  2004cited by this paper
• Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients.

  2004cited by this paper
• Peroxisome Proliferator–Activated Receptor Ligand Bezafibrate for Prevention of Type 2 Diabetes Mellitus in Patients With Coronary Artery Disease

  2004cited by this paper
• The diabetes prevention program

  2003cited by this paper
• Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study.

  2002cited by this paper
• Dietary Patterns and Risk for Type 2 Diabetes Mellitus in U.S. Men

  2002cited by this paper
• Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

  2002cited by this paper
• Nut and peanut butter consumption and risk of type 2 diabetes in women.

  2002cited by this paper
• Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam.

  2002cited by this paper
• Diabetes Therapeutics News

  2002cited by this paper
• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

  2002cited by this paper
• Pravastatin and the Development of Diabetes Mellitus: Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study

  2001cited by this paper
• Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men.

  2001cited by this paper
• A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians.

  2000cited by this paper
• Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial.

  2000cited by this paper
• Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.

  1999cited by this paper
• Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.

  1999cited by this paper
• Sibutramine and energy balance.

  1998cited by this paper
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

  1998cited by this paper
• Lifestyle Intervention in Overweight Individuals With a Family History of Diabetes

  1998cited by this paper
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

  1998cited by this paper
• Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study

  1997cited by this paper
• Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk.

  1997cited by this paper
• Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men.

  1996cited by this paper
• Acute Effect of Cigarette Smoking on Glucose Tolerance and Other Cardiovascular Risk Factors

  1996cited by this paper
• Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men

  1995cited by this paper
• Weight Loss in Severely Obese Subjects Prevents the Progression of Impaired Glucose Tolerance to Type II Diabetes: A longitudinal interventional study

  1994cited by this paper
• Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus.

  1991cited by this paper
• A prospective study of moderate alcohol drinking and risk of diabetes in women.

  1988cited by this paper

• Effects of Metformin on Body Weight Management and Markers of the Metabolic Syndrome in Persons with Normal Glucose Tolerance

  2022influential citation
• Therapeutic potential of metformin in normal glucose tolerant persons with metabolic syndrome

  2020cites this paper
• Aqueous extract from Pepino (Solanum muricatum Ait.) leaves ameliorated insulin resistance, hyperlipidemia, and hyperglycemia in mice with metabolic syndrome.

  2020cites this paper
• Chapter 32 – Insulin Resistance and the Metabolic Syndrome

  2018cites this paper
• CHAPTER 3 2 InsulIn ResIstance and the MetabolIc syndRoMe

  2017cites this paper
• Metformin Improves Insulin Secretion and Reduces Insulin Resistance in People at High Risk for Development of Type 2 Diabetes Mellitus and Cardiovascular Disease

  2016cites this paper
• Metformin Reduces Cardiometabolic Risk Factors in People at High Risk for Development of Type 2 Diabetes and Cardiovascular Disease

  2014influential citation
• "The metabolic syndrome... is dead": These reports are an exaggeration

  2011cites this paper